Catrin Jackson
Catrin is TOPRA's Content Writer. She is responsible for editing and proofreading content for Regulatory Rapporteur, TOPRA's monthly peer-reviewed journal. In addition to writing content for a range of projects, she also composes TOPRA's monthly membership newsletter, InTouch.
Industry newsGene therapy restores hearing in five children
Five children with hereditary deafness have had their hearing restored in both ears through gene therapy in a clinical trial.
Industry newsCritical need to address mpox strain, says WHO
The World Health Organization (WHO) has warned that it is crucial to address the spread of monkeypox as cases surge.
Industry newsWHO issues global warning on fake Ozempic medication
The WHO has issued a global alert on falsified semaglutide products used to treat type 2 diabetes and obesity in some countries.
Industry newsFirst human death from H5N2 avian flu recorded in Mexico
The World Health Organization (WHO) has confirmed the first human fatality from H5N2 avian (bird) flu in Mexico.
Industry newsFDA programme set to improve diversity in clinical trials
The US FDA’s Oncology Center of Excellence has launched an initiative to improve access to clinical trials for under-represented populations.
Industry newsUnchecked AMR could make COVID-19 pandemic ‘minor’
Professor Dame Sally Davies has warned that unchecked antimicrobial resistance could make the COVID-19 pandemic ’look minor’.
Industry newsAstraZeneca set to withdraw its COVID-19 vaccine
AstraZeneca has begun withdrawing its COVID-19 vaccine from the market because of greater availability of more up-to-date vaccines.
Industry newsMelanoma vaccine enters Phase III clinical trials
A personalised mRNA vaccine for a deadly form of skin cancer is being rolled out in an international Phase III clinical trial.
Industry newsDR Congo mining town sees novel monkeypox strain
A mutation strain of monkeypox has been identified in a mining town in the Democratic Republic of Congo (DRC), according to a preprint paper.
Industry newsParkinson’s drug slows progression of motor symptoms
A developmental drug has shown promise in slowing symptoms of motor deterioration in people with advanced forms of Parkinson’s.
Industry newsNovel antibiotic receives EMA’s recommendation
The European Medicines Agency has recommended marketing authorisation for an antibiotic which can treat multidrug-resistant infections.
Industry newsModified skin bacteria treats tumours in mice
A study from Stanford Medicine has developed a promising method to treat cancer using a type of bacteria which is found on skin.
Industry newsCutting antibiotic usage reduces resistance levels
Cutting the use of antibiotics in both humans and animals has shown a reduction in antimicrobial-resistant bacteria.
Industry newsUtah law to permit non-FDA-approved stem cell therapies
Utah has passed legislation that will allow patients to receive placental stem cell therapies without the need for FDA approval.
Industry newsCholera vaccine shortage puts millions at risk
The World Health Organization has declared a worldwide shortage of the oral cholera vaccine amid an upsurge in cases.
Industry newsRadio waves used to hijack E.coli bacteria to make medicines
Researchers have developed a method that uses high-frequency radio waves to temporarily open bacterial cell walls to introduce new DNA.
Industry newsSponge-on-a-string cuts wait time for Barrett’s diagnosis
A procedure to test for a precancerous condition of the oesophagus, which uses a novel medical device, is under trial in NHS England.
Industry newsMHRA reclassifies codeine linctus as prescription-only
Over-the-counter cough syrups which contain the opioid codeine have been reclassified as prescription-only medicines due to the risk of abuse.
Industry newsViolin resin works as cleaning agent for ‘superbugs’
A form of resin taken from a Norway spruce has been found to also function as an effective disinfectant against drug-resistant bacteria.
Industry newsAngioedemas caused by rare gene fault curable by CRISPR
A single dose of a CRISPR gene therapy has been shown to almost eliminate a rare genetic, inflammatory and potentially life-threatening condition.